$24.290
-0.605 (-2.49%)收盘时
SPTX 同业对比
In the context of the broader market, SPTX competes directly with industry leaders such as MLTX and MNKD. With a market capitalization of $1.30B, it holds a significant position in the sector. When comparing efficiency, SPTX's gross margin of N/A stands against MLTX's N/A and MNKD's 69.00%. Such benchmarking helps identify whether Seaport Therapeutics Inc is trading at a premium or discount relative to its financial performance.
Seaport Therapeutics Inc 财务表现
The company has a current ratio of 18.00, indicating strong liquidity, and total equity increased significantly to $422.6 million in Q2 2026, showing improved financial health.
Financials
FY2026Q2
-65.81M
Operating Profit
FY2026Q2
-62.36M
Net Income after Tax
FY2026Q2
-1.78
EPS - Diluted
FY2026Q2
-26.14M
Free Cash Flow
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。